Titan Pharmaceuticals
TTNP
#10532
Rank
โ‚น0.57 B
Marketcap
โ‚น429.22
Share price
-3.76%
Change (1 day)
25.65%
Change (1 year)

EPS for Titan Pharmaceuticals (TTNP)

EPS in 2025 (TTM): -โ‚น369.19

According to Titan Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is -โ‚น408.74. In 2023 the company made an earnings per share (EPS) of -โ‚น689.92 an increase over its 2022 EPS that were of -โ‚น1,414.

EPS history for Titan Pharmaceuticals from 1996 to 2025

Annual EPS

Year EPS Change
2025 (TTM)-โ‚น369.19
2023-โ‚น689.92-51.22%
2022-โ‚น1,414-15.61%
2021-โ‚น1,676-81.37%
2020-โ‚น8,994-77.52%
2019-โ‚น40,017-56.32%
2018-โ‚น91,617-59.51%
2017-โ‚น2,26,295-371.81%
2016โ‚น83,254-144.35%
2015-โ‚น1,87,703300%
2014-โ‚น46,926-121.54%
2013โ‚น2,17,870-151.38%
2012-โ‚น4,24,009-11.54%
2011-โ‚น4,79,314188.89%
2010-โ‚น1,65,916-10%
2009-โ‚น1,84,352
2007-โ‚น7,55,841-2.38%
2006-โ‚น7,74,276-39.13%
2005-โ‚น12,72,026-16.87%
2004-โ‚น15,30,118-22.43%
2003-โ‚น19,72,5624.9%
2002-โ‚น18,80,38661.9%
2001-โ‚น11,61,415-13.7%
2000-โ‚น13,45,76665.01%
1999-โ‚น8,15,580-35.87%
1998-โ‚น12,71,809-1824.71%
1997โ‚น73,741-102.4%
1996-โ‚น30,78,671

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
โ‚น1,037-353.73%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
โ‚น670.36-264.01%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Vanda Pharmaceuticals
VNDA
-โ‚น132.21-67.65%๐Ÿ‡บ๐Ÿ‡ธ USA
Repligen
RGEN
โ‚น81.00-119.82%๐Ÿ‡บ๐Ÿ‡ธ USA
MediciNova
MNOV
-โ‚น23.28-94.31%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-โ‚น362.18-11.39%๐Ÿ‡บ๐Ÿ‡ธ USA